Online Abstract Submission

Rules and Regulations The Abstract Form
How to Prepare an Abstract The Payment Form
Filling in the Abstract and Payment Forms Sample Abstract

Information for Authors

All abstracts are to be submitted electronically. ALL ABSTRACTS ARE DUE ON January 31, 1998. There can be no exceptions made to this deadline.


Rules and Regulations

ONLY ONE PAPER OR POSTER MAY BE READ OR PRESENTED BY THE SAME AUTHOR AT THE MEETING, although a presenter may be co-author of any number of papers. A time limit of 10 minutes for oral presentation will be strictly enforced. The material must not have been published or presented at any national meeting prior to the date of presentation. Simultaneous submission of the same abstract to other societies (for example, the SID or AAD) is prohibited. Abstracts will be judged on the basis of scientific merit. If the presenter is not able to give a clear presentation in English, the poster option should be chosen on the form. All oral presentations should begin with a general introduction to orient those not in the field to the significance of the work.



Preparation of the Abstract

Abstracts must conform to the following standards.

1. Do not use graphics or tables.

2. The entire abstract, including title, author(s), affiliation, location and text must be typed single-spaced on the lines on this form. Leave no space between the title and body of the abstract or between paragraphs.

3. The title must be brief and indicate clearly the nature of the investigation. Capitalize the entire title. Abbreviations must not be used in the title. Begin the title at the left-hand margin; do not indent. Immediately after the title, continuing on the same line if possible, state all authors' names. Initials or first names must precede the last name. Authors' names should be typed with upper and lowercase letters. Authors' names must be continuously underlined. Degrees and titles must not be used. Continuing on the same line, if possible, give institutional affiliation, city and state. Two-letter abbreviations for the state may be used. Institutional abbreviations must conform to standard usage. Street address and zip codes are not listed.

4. Begin the body of the abstract on a new line and indent three spaces on this and other paragraphs. Do not use capitals or underline for emphasis in the text.

5. The abstract should be organized as follows: (a) a sentence describing the purpose of the study; (b) a statement of experimental design or method used; (c) a summary of results, presented in sufficient detail to support the conclusion; and (d) a statement of conclusions reached. It is not satisfactory to state "The results will be discussed..." or "Other data will be presented." Do not use subtitles, e.g., methods, results, etc. within the body of the abstract. Failure to follow this format will result in a low priority score and may cause disqualification of your abstract.

6. Nonproprietary (generic) names should be given the first time a drug is mentioned in the body of the abstract and should be written in small letters. The first letter of a proprietary name is always capitalized, e.g., cyproheptadine (Periactin).

7. Do not mention support of work by a research grant.



Payment:

At this time, electronic submission of abstracts is available only to those members who are willing to send by fax MasterCard or Visa payment of the abstract submission fee. A separate form linked here must be faxed to the IDS office by January 31, 1998.



Sample Abstract Layout

IDENTIFICATION OF A POTENTIAL PATHWAY LINKING INHIBITION OF RETINOID SIGNALLING WITH DISRUPTION OF EPIDERMAL LIPID BARRIER FUNCTION IN TRANSGENIC MICE CONJUGATE.

J.R. Bickenbach, P.S. Attar, S. Imakado, J.A. Rothnagel, P.W. Wertz, D.R. Roop. The University of Iowa, Iowa City, Iowa; Baylor College of Medicine, Houston, Texas.

Previous transgenic mice resulting from targeted disruption of retinoic acid receptors (RAR-alpha or -gamma) or retinoid X receptor (RXR-alpha) genes either failed to exhibit a skin phenotype, suggesting functional, etc.



How to Fill Out the Electronic Abstract Form

Forms require an updated net browser. Click here to download the latest Netscape browser.

The title must be identical among the forms.

Form 1 , The abstract submission form. Fill out the form, then press the button on the bottom to submit the abstract. Print out the page which states, "Your record has been successfully added to the database." Print this page as a receipt of your submission.

Form 2 , The IDS payment page. Fill out the form and fax it to the IDS with your payment. The IDS fax number is (203) 324-5719.


Send your comments to:
Rhett Drugge, M.D.
Last update: September 8, 1997